Altimmune, Inc.·4

Aug 3, 4:05 PM ET

Eisenstadt Richard I 4

4 · Altimmune, Inc. · Filed Aug 3, 2022

Insider Transaction Report

Form 4
Period: 2022-07-31
Eisenstadt Richard I
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    2022-07-31$6.86/sh+1,366$9,3711,366 total
Footnotes (1)
  • [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2022 through July 31, 2022.

Documents

1 file
  • 4
    tm2222488-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT